Vale Scientia Professor David Cooper

Cate Swannell
Med J Aust
Published online: 19 March 2018

THE Australian and international medical communities are in mourning following the death of HIV/AIDS research pioneer Scientia Professor David Cooper, the long-time Director of the Kirby Institute at the University of New South Wales.

Professor Cooper was a regular contributor to the Medical Journal of Australia, both as an author and a reviewer. A list of his published articles in the MJA can be found at the end of this article.

The Kirby Institute issued the following press release:

The Kirby Institute at UNSW Sydney is mourning the loss of our Director, Scientia Professor David Cooper, who passed away on Sunday afternoon after a short illness.

David’s life was dedicated to the prevention, treatment and cure of HIV and other infectious diseases.These diseases disproportionately affect the world’s most disadvantaged communities, and David firmly advocated health as a fundamental human right in all of his endeavours. His leadership as a clinician and researcher was extraordinary, and it is difficult to imagine our many collaborative efforts without David at the helm.

David was our inaugural Director at the establishment, in 1986, of the research centre that ultimately became the Kirby Institute, so he has served as Director for the entirety of our history. David was among the first responders when the HIV epidemic reached Australia in the 1980s, and has been pivotal in the ongoing fight against HIV. David was an internationally renowned leader, initiating ground-breaking, collaborative infectious disease research that has saved countless lives in Australia, and globally.

“David’s special gift was having both a huge intellect and a huge heart. It was his intellect that made him a leader in the global response to the AIDS epidemic and led to the building of the Kirby Institute. But it was his great heart that all who knew him, his family, his colleagues and his patients, could witness every day. He was first a clinician, and that made him a great scientist,” said The Hon. Michael Kirby, who was a close friend of David, and in whose honour our Institute is named. “We will miss him terribly and be all too aware of his absence.”

David’s record of clinical and academic achievement is unparalleled. In the mid-1980s, his research led to the first description of the seroconversion illness which accompanies initial HIV infection in many people. He then proceeded to take a leading role in most of the key trials that ultimately led to the optimal use of life-saving combination treatments that are now widely available to people with HIV all over the world. In 2003, he was made Officer in the General Division of the Order of Australia (AO) for “service to medicine as a clinician, researcher and leading contributor in the field of HIV/AIDS research and to the development of new treatment approaches.” David was working right up to the time of his illness, running large-scale international clinical trials to improve HIV treatment, building research capacity in Indonesia and Myanmar, and leading the trial of pre-exposure prophylaxis to eliminate HIV transmission in New South Wales

Under David’s leadership, the Kirby Institute grew from a national centre with a handful of staff formed to respond to the emerging HIV crisis, into what is now a globally renowned research institute with more than 300 staff and students, working at the forefront of the latest discoveries and innovations in HIV, viral hepatitis and sexually transmissible infections.

Our Institute is David’s legacy, and while we are devastated to lose him, we carry on his work with immense dedication, honour and pride.

Though he was humble about his scientific achievements, David spoke with the greatest pride about his family. His wife Dorrie and their daughters Becky and Ilana were as unfailingly supportive of his work as he was of them. To them we extend our deepest condolences.

Vale David. Our Director, our mentor, our friend.

The staff of the Medical Journal of Australia, and MJA InSight, extend our condolences to the family, friends and colleagues of Scientia Professor David Cooper.

Articles by David Cooper:

Consensus statement: Sexual transmission of HIV and the law: an Australian medical consensus statement

Editorial: The end of HIV: how do we get there?

Editorial: The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV

Updates in medicine: HIV medicine

Editorial: Bridging the divide: global inequities in access to HIV/AIDS therapy

Research: HIV disease progression in Australia in the time of combination antiretroviral therapies

  • Cate Swannell



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.